These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


102 related items for PubMed ID: 9105418

  • 1. Immortal, non-tumourigenic mouse mammary outgrowths express high levels of cyclin B1 and activation of cyclin B1/cdc2 kinase.
    Said TK, Bonnette S, Medina D.
    Cell Prolif; 1996 Nov; 29(11):623-39. PubMed ID: 9105418
    [Abstract] [Full Text] [Related]

  • 2. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
    Said TK, Moraes RC, Singh U, Kittrell FS, Medina D.
    Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
    [Abstract] [Full Text] [Related]

  • 3. Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4.
    Said TK, Luo L, Medina D.
    Carcinogenesis; 1995 Oct; 16(10):2507-13. PubMed ID: 7586159
    [Abstract] [Full Text] [Related]

  • 4. Immortalization phenotype dissociated from the preneoplastic phenotype in mouse mammary epithelial outgrowths in vivo.
    Medina D, Kittrell FS.
    Carcinogenesis; 1993 Jan; 14(1):25-8. PubMed ID: 8425268
    [Abstract] [Full Text] [Related]

  • 5. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK, Medina D.
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [Abstract] [Full Text] [Related]

  • 6. Tyrosine phosphorylation in mouse mammary hyperplasias.
    Said TK, Medina D.
    Carcinogenesis; 1995 Apr; 16(4):923-30. PubMed ID: 7728975
    [Abstract] [Full Text] [Related]

  • 7. Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation.
    Nandan MO, Chanchevalap S, Dalton WB, Yang VW.
    FEBS Lett; 2005 Aug 29; 579(21):4757-62. PubMed ID: 16102754
    [Abstract] [Full Text] [Related]

  • 8. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses.
    Kawamoto H, Koizumi H, Uchikoshi T.
    Am J Pathol; 1997 Jan 29; 150(1):15-23. PubMed ID: 9006317
    [Abstract] [Full Text] [Related]

  • 9. Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma : relationship to cell death, proliferation, and transformation.
    Banerjee SK, Weston AP, Zoubine MN, Campbell DR, Cherian R.
    Am J Pathol; 2000 Jan 29; 156(1):217-25. PubMed ID: 10623670
    [Abstract] [Full Text] [Related]

  • 10. Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression.
    Mohapatra S, Yang X, Wright JA, Turley EA, Greenberg AH.
    J Exp Med; 1996 Apr 01; 183(4):1663-8. PubMed ID: 8666924
    [Abstract] [Full Text] [Related]

  • 11. The cell cycle in polyploid megakaryocytes is associated with reduced activity of cyclin B1-dependent cdc2 kinase.
    Zhang Y, Wang Z, Ravid K.
    J Biol Chem; 1996 Feb 23; 271(8):4266-72. PubMed ID: 8626773
    [Abstract] [Full Text] [Related]

  • 12. Growth and differentiation of hyperplastic outgrowths derived from mouse mammary epithelial cells transformed in organ culture.
    Ganguly N, Ganguly R, Mehta NM, Banerjee MR.
    J Natl Cancer Inst; 1982 Aug 23; 69(2):453-63. PubMed ID: 6810005
    [Abstract] [Full Text] [Related]

  • 13. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA, Kittrell FS, Medina D, Butel JS.
    Oncogene; 2001 Nov 15; 20(52):7645-57. PubMed ID: 11753642
    [Abstract] [Full Text] [Related]

  • 14. Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin.
    Janss AJ, Maity A, Tang CB, Muschel RJ, McKenna WG, Sutton L, Phillips PC.
    Neuro Oncol; 2001 Jan 15; 3(1):11-21. PubMed ID: 11305412
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
    Weroha SJ, Li SA, Tawfik O, Li JJ.
    Carcinogenesis; 2006 Mar 15; 27(3):491-8. PubMed ID: 16311245
    [Abstract] [Full Text] [Related]

  • 16. Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage.
    Shimizu T, O'Connor PM, Kohn KW, Pommier Y.
    Cancer Res; 1995 Jan 15; 55(2):228-31. PubMed ID: 7812949
    [Abstract] [Full Text] [Related]

  • 17. Cell cycle attenuation by p120E4F is accompanied by increased mitotic dysfunction.
    Rooney RJ.
    Cell Growth Differ; 2001 Oct 15; 12(10):505-16. PubMed ID: 11682462
    [Abstract] [Full Text] [Related]

  • 18. Promotion-sensitive epidermal and mammary epithelial cells maintained in suspension over agarose.
    Eto I.
    Cell Prolif; 1998 Apr 15; 31(2):71-92. PubMed ID: 9745617
    [Abstract] [Full Text] [Related]

  • 19. Genesis and evolution of high-ploidy tumour cells evaluated by means of the proliferation markers p34(cdc2), cyclin B1, PCNA and 3[H]-thymidine.
    Baroja A, de la Hoz C, Alvarez A, Ispizua A, Bilbao J, de Gandarias JM.
    Cell Prolif; 1996 Feb 15; 29(2):89-100. PubMed ID: 8630339
    [Abstract] [Full Text] [Related]

  • 20. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
    Vikhanskaya F, Erba E, D'Incalci M, Broggini M.
    Exp Cell Res; 1996 Sep 15; 227(2):380-5. PubMed ID: 8831577
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.